Nu Skin Enterprises (NUS) Tops Q1 EPS by 11c; Guides Above Views
Nu Skin Enterprises (NYSE: NUS) reported Q1 EPS of $0.36, $0.11 better than the analyst estimate of $0.25. Revenue for the quarter came in at $518 million versus the consensus estimate of $480.83 million.
"The efforts and resiliency of our sales leaders and global teams helped us achieve revenue and earnings above guidance in the first quarter," said Ritch Wood, chief executive officer. "While COVID-19 continues to present significant challenges globally, we are grateful for the heroic efforts of healthcare workers, first responders and other essential workers around the world. From a Nu Skin perspective, our entire organization has mobilized to protect the health and safety of our teams and ensure business continuity for our customers. As a result, we have been able to maintain support for our sales leaders, leverage our supply chain to meet consumer demand for our products and utilize technology to facilitate remote work for both our sales leaders and employees."
"Our first quarter results demonstrated continued stability in the Nu Skin business with strong customer activity. More than 80 percent of our revenue comes through our digital properties which have been enhanced by our strategic investments in technology infrastructure and digital tools. Additionally, our manufacturing and supply chain investments have enabled us to effectively manage inventory and fulfill customer orders worldwide through very challenging circumstances. Our manufacturing segment performed well considering the supply chain disruptions related to certain ingredients and packaging materials due to the pandemic. We generated solid cash flow during the quarter, increased our dividend for the 19th consecutive year and utilized our cash to repurchase shares in a way that we believe will benefit shareholders going forward," continued Wood.
GUIDANCE:
Nu Skin Enterprises sees Q2 2020 EPS of $0.42-$0.52, versus the consensus of $0.44. Nu Skin Enterprises sees Q2 2020 revenue of $520-550 million, versus the consensus of $507.2 million.
Nu Skin Enterprises sees FY2020 EPS of $2.05-$2.35, versus the consensus of $2.01. Nu Skin Enterprises sees FY2020 revenue of $2.17-2.26 billion, versus the consensus of $2.11 billion.
For earnings history and earnings-related data on Nu Skin Enterprises (NUS) click here.
